🚀 VC round data is live in beta, check it out!
Lumito Valuation Multiples
Discover revenue and EBITDA valuation multiples for Lumito and similar public comparables like Attana, Level Bio, Elite Diagnostic, NanoEcho and more.
Lumito Overview
About Lumito
Lumito AB is a Swedish company that specializes in the medical research and development of imaging technology for use in digital pathology. It has developed the next-generation tissue analysis system, based on upconverting nanoparticles (UCNPs). Lumito SCIZYS is a cutting-edge, high-sensitivity system combining labeling and imaging technologies to locate and measure biomarkers in tissue samples. The company holds a broad patent portfolio of three patent families. Lumito’s solution enables quantitative and objective assessment of tissue samples, addressing a multitude of challenges in drug development and academic research.
Founded
2010
HQ
Employees
12
Website
Financials (LTM)
EV
$1M
Lumito Financials
Lumito reported last 12-month revenue of $62K and negative EBITDA of ($2M).
In the same LTM period, Lumito generated ($2M) in EBITDA losses and had net loss of ($5M).
Lumito P&L
In the most recent fiscal year, Lumito reported revenue of — and EBITDA of ($2M).
Lumito expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $62K | XXX | — | XXX | XXX | XXX |
| Gross Profit | — | XXX | $18K | XXX | XXX | XXX |
| EBITDA | ($2M) | XXX | ($2M) | XXX | XXX | XXX |
| EBITDA Margin | (4000%) | XXX | — | XXX | XXX | XXX |
| EBIT Margin | (7444%) | XXX | — | XXX | XXX | XXX |
| Net Profit | ($5M) | XXX | ($5M) | XXX | XXX | XXX |
| Net Margin | (7757%) | XXX | — | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Lumito Stock Performance
Lumito has current market cap of $2M, and enterprise value of $1M.
Market Cap Evolution
Lumito's stock price is $0.60.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1M | $2M | 0.0% | XXX | XXX | XXX | $-1.39 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLumito Valuation Multiples
Lumito trades at 22.7x EV/Revenue multiple, and (0.6x) EV/EBITDA.
Lumito Financial Valuation Multiples
As of April 20, 2026, Lumito has market cap of $2M and EV of $1M.
Equity research analysts estimate Lumito's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Lumito has a P/E ratio of (0.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV (current) | $1M | XXX | $1M | XXX | XXX | XXX |
| EV/Revenue | 22.7x | XXX | — | XXX | XXX | XXX |
| EV/EBITDA | (0.6x) | XXX | (0.6x) | XXX | XXX | XXX |
| EV/EBIT | (0.3x) | XXX | (0.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 78.5x | XXX | XXX | XXX |
| P/E | (0.4x) | XXX | (0.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (0.5x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lumito Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Lumito Margins & Growth Rates
Lumito's revenue in the last 12 month grew by 598%.
Lumito's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.
Lumito Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 598% | XXX | (100%) | XXX | XXX | XXX |
| EBITDA Margin | (4000%) | XXX | — | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | 7% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Lumito Public Comps
See public comps and valuation multiples for other Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Lumito | XXX | XXX | XXX | XXX | XXX | XXX |
| Attana | XXX | XXX | XXX | XXX | XXX | XXX |
| Level Bio | XXX | XXX | XXX | XXX | XXX | XXX |
| Elite Diagnostic | XXX | XXX | XXX | XXX | XXX | XXX |
| NanoEcho | XXX | XXX | XXX | XXX | XXX | XXX |
| Epigenomics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lumito M&A Activity
Lumito acquired XXX companies to date.
Last acquisition by Lumito was on XXXXXXXX, XXXXX. Lumito acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Lumito
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLumito Investment Activity
Lumito invested in XXX companies to date.
Lumito made its latest investment on XXXXXXXX, XXXXX. Lumito invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Lumito
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lumito
| When was Lumito founded? | Lumito was founded in 2010. |
| Where is Lumito headquartered? | Lumito is headquartered in Sweden. |
| How many employees does Lumito have? | As of today, Lumito has over 12 employees. |
| Is Lumito publicly listed? | Yes, Lumito is a public company listed on Nasdaq Global Market. |
| What is the stock symbol of Lumito? | Lumito trades under LUMITO TO6 ticker. |
| When did Lumito go public? | Lumito went public in 2018. |
| Who are competitors of Lumito? | Lumito main competitors are Attana, Level Bio, Elite Diagnostic, NanoEcho. |
| What is the current market cap of Lumito? | Lumito's current market cap is $2M. |
| What is the current revenue of Lumito? | Lumito's last 12 months revenue is $62K. |
| What is the current revenue growth of Lumito? | Lumito revenue growth (NTM/LTM) is 598%. |
| What is the current EV/Revenue multiple of Lumito? | Current revenue multiple of Lumito is 22.7x. |
| Is Lumito profitable? | No, Lumito is not profitable. |
| What is the current EBITDA of Lumito? | Lumito has negative EBITDA and is not profitable. |
| What is Lumito's EBITDA margin? | Lumito's last 12 months EBITDA margin is (4000%). |
| What is the current EV/EBITDA multiple of Lumito? | Current EBITDA multiple of Lumito is (0.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.